PnPP-15, a Synthetic Peptide Derived from a Toxin from Phoneutria nigriventer Spider Venom, Alleviates Diabetic Neuropathic Pain and Acts Synergistically with Pregabalin in Mice
Open Access
Abstract
Diabetic neuropathic pain is one of the complications that affect a wide variety of the diabetic population and is often difficult to treat. Only a small number of patients experience pain relief, which usually comes with onerous side effects and low levels of satisfaction. The search for new analgesic drugs is necessary, given the limitations that current drugs present. Combining drugs to treat neuropathic pain has been attracting interest to improve their efficacy compared to single-drug monotherapies while also reducing dose sizes to minimize side effects. The aim of our study was to verify the antinociceptive effect of a synthetic peptide, PnPP-15, alone and combined with pregabalin, in male Swiss diabetic mice using the von Frey method. PnPP-15 is a synthetic peptide derived from PnPP19, a peptide representing a discontinuous epitope of the primary structure of the toxin PnTx2-6 from the venom of the spider Phoneutria nigriventer. The antinociceptive activity of both compounds was dose-dependent and showed synergism, which was verified by isobolographic analysis. Treatment with PnPP-15 did not cause spontaneous or forced motor changes and did not cause any damage or signs of toxicity in the analyzed organs (pancreas, lung, heart, kidney, brain, or liver). In conclusion, PnPP-15 is a great candidate for an analgesic drug against neuropathic pain caused by diabetes and exerts a synergistic effect when combined with pregabalin, allowing for even more efficient treatment.Keywords
Funding Information
- CNPq (304337/2019-6, 88881.284131/2018-01)
- CAPES (304337/2019-6, 88881.284131/2018-01)
This publication has 38 references indexed in Scilit:
- Opioid and cannabinoid synergy in a mouse neuropathic pain modelBritish Journal of Pharmacology, 2016
- PnPP‐19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidaseBritish Journal of Pharmacology, 2016
- PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMPJournal of Urology, 2015
- Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disordersJournal of Venomous Animals and Toxins including Tropical Diseases, 2015
- Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisThe Lancet Neurology, 2015
- Treating Diabetic Neuropathy: Present Strategies and Emerging SolutionsThe Review of Diabetic Studies, 2015
- Cannabinoid–opioid interactions during neuropathic pain and analgesiaCurrent Opinion in Pharmacology, 2010
- Interaction of the cannabinoid and opioid systems in the modulation of nociceptionInternational Review of Psychiatry, 2009
- Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responsesEuropean Neuropsychopharmacology, 2003
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994